Narayana Health

Sector: Healthcare Services — Hospitals  |  HQ: Bengaluru, Karnataka  |  Founded: 2000  |  Employees: ~21,000

Listed as: NSE / BSE listed (NARAYANA.NS)  |  NSE / BSE  |  Ticker: NARAYANA.NS  |  Website →

Company overview

Narayana Health is a leading chain of multi-specialty hospitals in India founded by Dr. Devi Shetty. The network operates over 20 hospitals across Karnataka, West Bengal, Rajasthan, Gujarat, and other states, offering cardiac care, oncology, orthopedics, nephrology, and general medicine. The group is known for its high-quality, affordable healthcare and is recognized as one of India's most cost-effective hospital chains.

Recent developments

May 2026

Narayana Health is executing a significant international expansion strategy, highlighted by its entry into the United Kingdom through the acquisition of Practice Plus Group for approximately Rs 2,200 crore ($248 million) [3][4]. This landmark deal positions Narayana Health among India's top three hospital operators by scale and marks its first major inorganic growth move outside the domestic market [4]. The acquisition was completed in late 2025, establishing a direct operational footprint in the U.K. healthcare sector [9][10].

On the domestic front, Narayana Health achieved a notable digital health milestone when its Institute of Cardiac Sciences became India's first hospital to attain HIMSS AMAM Stage 6 certification, reflecting advanced digital infrastructure maturity [1]. Separately, the health system partnered with Airbound to pilot drone-based medical logistics between its Chandapura Clinic and Electronic City laboratory, signaling early-stage exploration of automated supply chain solutions for improved diagnostic turnaround times [5][8].

Sources (7)

1. Narayana Institute of Cardiac Sciences becomes India's first HIMSS AMAM Stage 6 hospital - Healthcare IT News · Healthcare IT News · Thu, 21 May 2026
2. Indian Billionaire Devi Shetty’s Narayana Health To Enter U.K. Market In $248 Million Deal - Forbes · Forbes · Mon, 03 Nov 2025
3. Narayana Health enters UK, acquires Practice Plus Group; with Rs 2.2K-cr buy, company among India’s top 3 - The Times of India · The Times of India · Sat, 01 Nov 2025
4. Narayana Health and Airbound complete drone logistics pilot between Chandapura Clinic and Electronic City laboratory - expresshealthcare.in · expresshealthcare.in · Wed, 18 Mar 2026
5. Narayana Health, Airbound are reimagining medical logistics in India - YourStory.com · YourStory.com · Tue, 17 Mar 2026
6. Narayana Health Expands into UK with Acquisition of Practice Plus Group Hospitals - NDTV · NDTV · Fri, 31 Oct 2025
7. Narayana Health moves into UK - Healthcare Today · Healthcare Today · Sat, 01 Nov 2025

Financial performance and recent trajectory

Disclosed revenue (FY25): Not separately disclosed in segment-wise FY 2024-25 reporting.

Competitive position

Narayana Health competes with major hospital chains including Manipal Hospitals, Aster DM Healthcare, Fortis Healthcare, Max Healthcare, and Apollo Hospitals, positioning itself as a cost-effective alternative with particular strength in cardiac care.

Key risks

Regulatory changes in healthcare pricing and reimbursement policies Shortage of qualified medical professionals in Tier 2/3 cities Competition from well-funded hospital chains expanding aggressively Operational challenges in maintaining quality across geographically dispersed facilities

Outlook

Narayana Health is a participant in the Indian multispecialty hospital category, which forms part of the broader Pharma & Healthcare space. The Indian multispecialty hospital market continues to evolve with rising organised share, premiumisation, distribution expansion, and a regulatory architecture covering the Companies Act 2013, the Income Tax Act 1961, the CGST Act 2017, the Legal Metrology Act 2009, and sectoral statutes including the Food Safety and Standards Act 2006 (for food and beverage subsegments), the Drugs and Cosmetics Act 1940 (for pharmaceutical or healthcare adjacencies), the Environment Protection Act 1986 (for emissions and effluents), and labour codes consolidated under the four 2020 labour codes. In KAMRIT's project report framework for this category, the competitive set typically includes pan-India branded leaders, multinational subsidiaries, mid-sized regional players, and a long tail of MSME participants. The structural attractiveness of the category for new entrants is a function of (a) market growth rate, (b) the share that remains with unorganised or fragmented operators, (c) the cost of regulatory compliance, and (d) the capex intensity of plant and machinery. The KAMRIT bankable DPR for this category structures a new entrant's economics against this competitive landscape. For Narayana Health specifically, public-domain disclosures provide a baseline view of operations, but segment-wise revenue, EBITDA, capacity utilisation, and forward capex plans are not separately broken out in many cases. Where the company is part of a listed group, the SEBI LODR and the Companies Act 2013 governance framework apply, with statutory audit conducted under SA 700 and CARO 2020 reporting. Where the company is unlisted, the Companies Act 2013 framework continues to govern with reduced public disclosure. The risk and opportunity outlook for Narayana Health mirrors the broader multispecialty hospital category dynamics. Demand-side drivers include rising household consumption, urbanisation, organised retail expansion, and policy support including PLI schemes (where applicable to the segment). Supply-side risks include input cost volatility, regulatory tightening, environmental compliance escalation, and competitive intensity from larger groups or imports. Management quality, balance sheet strength, distribution depth, and the capex execution track record are the differentiators within the peer set. KAMRIT's research desk maintains a baseline reference for Narayana Health as a peer benchmark within the multispecialty hospital category. For investors, lenders, or new entrant promoters seeking a fuller assessment of Narayana Health, KAMRIT's deep-dive company profile engagement covers financial trajectory, capacity and capex, distribution and customer concentration, regulatory exposure, and the competitive position with named peers.

KAMRIT point of view

Building or competing with Narayana?

KAMRIT advises promoters, family offices, and global enterprises evaluating greenfield entry into the healthcare services — hospitals sector. Our Bankable DPR with Cost Model and ROI benchmarks your project economics against the listed-company cost structure of Narayana and peers. The Execution Partnership tier covers everything from incorporation through commissioning. A 20-minute scoping call with our partners is free.

View all 1 related project report → Book a scoping call

Related KAMRIT project reports

These reports use Narayana Health in benchmarking and competitive analysis sections.

Disclaimer: This profile is compiled by KAMRIT Financial Services LLP for educational and benchmarking purposes only. It is not investment advice, a recommendation to buy or sell securities, or a solicitation. Stock data is provided by Yahoo Finance and may be delayed by up to 20 minutes. Company financial commentary draws on publicly available filings, exchange disclosures, and KAMRIT industry research. Readers should consult a SEBI-registered investment adviser before making investment decisions. KAMRIT is a financial services and compliance firm, not a SEBI-registered investment adviser.